[
  {
    "ts": null,
    "headline": "GILD or AMGN: Which Is the Better Value Stock Right Now?",
    "summary": "GILD vs. AMGN: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=4a606a31dbc49f767cf9afc7f05806d74555d9134bd2e4120d87627ed51612d3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743522007,
      "headline": "GILD or AMGN: Which Is the Better Value Stock Right Now?",
      "id": 133655234,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "GILD vs. AMGN: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=4a606a31dbc49f767cf9afc7f05806d74555d9134bd2e4120d87627ed51612d3"
    }
  },
  {
    "ts": null,
    "headline": "Dow falls nearly 150 points on losses for Johnson & Johnson, Merck shares",
    "summary": "Dow falls nearly 150 points on losses for Johnson & Johnson, Merck shares",
    "url": "https://finnhub.io/api/news?id=c9d70736961831c69fccafebef0832d2e0f9e5e864e8e345b889072023cf7e19",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743521400,
      "headline": "Dow falls nearly 150 points on losses for Johnson & Johnson, Merck shares",
      "id": 133658793,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Dow falls nearly 150 points on losses for Johnson & Johnson, Merck shares",
      "url": "https://finnhub.io/api/news?id=c9d70736961831c69fccafebef0832d2e0f9e5e864e8e345b889072023cf7e19"
    }
  },
  {
    "ts": null,
    "headline": "Dogs Of The Dow Chase April's 'Safer' Buy",
    "summary": "Dogs Of The Dow Chase April's 'Safer' Buy",
    "url": "https://finnhub.io/api/news?id=2feed9044f044f2d4cb8422e3537e5db1ce869843f4c4367a375d4fa0a997d66",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743509147,
      "headline": "Dogs Of The Dow Chase April's 'Safer' Buy",
      "id": 133646857,
      "image": "",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=2feed9044f044f2d4cb8422e3537e5db1ce869843f4c4367a375d4fa0a997d66"
    }
  },
  {
    "ts": null,
    "headline": "Nvidia, Other Techs Hurt Dow Jones, But These Names Outperformed In Q1",
    "summary": "The overseers of the Dow Jones Industrial Average might regret adding Nvidia to the index.  Since it joined the Dow industrials on Nov. 7, Nvidia stock is down nearly 30%.  Nvidia stock is on track for its worst month since September 2022, when it lost nearly 20%, according to Dow Jones Market Data.",
    "url": "https://finnhub.io/api/news?id=97e400b522bf5e518c45d955870c9c3706affed7b7ff749600e31a67ec75a38d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743507861,
      "headline": "Nvidia, Other Techs Hurt Dow Jones, But These Names Outperformed In Q1",
      "id": 133645081,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "The overseers of the Dow Jones Industrial Average might regret adding Nvidia to the index.  Since it joined the Dow industrials on Nov. 7, Nvidia stock is down nearly 30%.  Nvidia stock is on track for its worst month since September 2022, when it lost nearly 20%, according to Dow Jones Market Data.",
      "url": "https://finnhub.io/api/news?id=97e400b522bf5e518c45d955870c9c3706affed7b7ff749600e31a67ec75a38d"
    }
  },
  {
    "ts": null,
    "headline": "These biotech names aren't facing 'huge concern' from tariffs",
    "summary": "Trump's upcoming tariffs has the potential to bring biopharma manufacturing to the US, which could impact companies with overseas production. Jefferies managing director Michael Yee joins Market Domination Overtime to discuss how tariffs could impact the biotech sector, emphasizing Vertex (VRTX), Amgen (AMGN), and Gilead (GILD) as some of his top large-cap picks in the sector. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.",
    "url": "https://finnhub.io/api/news?id=3c95152d520015603efbbfe60d018817dd7753417c24b8ffe43796a8e6ed66ce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743507025,
      "headline": "These biotech names aren't facing 'huge concern' from tariffs",
      "id": 133645380,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Trump's upcoming tariffs has the potential to bring biopharma manufacturing to the US, which could impact companies with overseas production. Jefferies managing director Michael Yee joins Market Domination Overtime to discuss how tariffs could impact the biotech sector, emphasizing Vertex (VRTX), Amgen (AMGN), and Gilead (GILD) as some of his top large-cap picks in the sector. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.",
      "url": "https://finnhub.io/api/news?id=3c95152d520015603efbbfe60d018817dd7753417c24b8ffe43796a8e6ed66ce"
    }
  }
]